Mounjaro Savings Card in 2026

Only one route gets you there: commercial insurance that COVERS Mounjaro, plus the Mounjaro Savings Card applied on top. The card pays a maximum of $150 per 1-month fill ($300 on a 2-month supply, $450 on a 3-month), which is what decides whether $25 is reachable for you: a copay of $175 or less lands in that range, a copay of $400 still leaves you paying $250. Subtract $150 from your own copay before you plan around the advertised number. Everything else you will read about getting Mounjaro for $25 assumes coverage and does not say so.

You cannot, and any page implying otherwise is misreading the card. The $25 figure is a COPAY reduction — it reduces what your insurance leaves you to pay, so with no coverage there is nothing for it to reduce. Without coverage the card takes at most $150 a month off a list price of roughly $1,080, and Lilly runs no cash self-pay programme for Mounjaro the way it does for Zepbound. If you are uninsured, the realistic routes are Zepbound self-pay at $299–$699 depending on dose, an FDA-approved oral option from $149, or asking your prescriber whether a different medication fits.

With commercial insurance that covers Mounjaro, the Mounjaro Savings Card brings the copay to as low as $25 for a 1-, 2-, or 3-month supply (maximum $150 savings per fill, with an annual cap). If your plan does NOT cover Mounjaro, the card only takes up to $150/month off the ~$1,080 list price — there is no manufacturer cash self-pay program for Mounjaro, so it stays expensive without coverage.

You need a valid US prescription for type 2 diabetes and commercial (non-government) insurance. The lowest price ($25 tier) requires that your commercial plan actually covers Mounjaro. Anyone enrolled in Medicare, Medicaid, TRICARE, VA, or any government plan cannot use the card — federal law bars manufacturer copay cards on government coverage.

Mounjaro is FDA-approved for type 2 diabetes, not weight management, so using it for weight loss is off-label and the savings card / insurance rarely apply for that use. For weight loss, the same molecule (tirzepatide) is sold as Zepbound, which has its own savings card and Lilly self-pay vials from $299/month. See our Zepbound cost and cheapest-tirzepatide guides.

Federal anti-kickback law prohibits drug manufacturers from offering copay cards to anyone enrolled in a government health program. This applies to every brand-drug copay card, not just Mounjaro. If you have Medicare or Medicaid, your options are a formulary appeal or a Part D plan that covers it — the manufacturer card is not available to you.

For type 2 diabetes, ask your prescriber about other covered GLP-1s (Ozempic, Trulicity) or the patient-assistance program. There is no cheap cash route for Mounjaro itself. If your real goal is weight loss, Zepbound (tirzepatide, same molecule) has Lilly self-pay vials that are far below Mounjaro's cash price.